Join our 20.000 subscribers and receive the monthly newsletter for free!

RELATED ARTICLES
Costs for treatment of HIV

The University of Hasselt and the AIDS Reference Centre of Ghent University Hospital calculated that the treatment for people infected with HIV in…


Galapagos thinks big

Galapagos, the Mechelen biotech company, quit its inflammation alliance with Janssen under mutual agreement. Galapagos regained the proprietary ri…


Mithra to become the new Omega Pharma?

Businessman Marc Coucke has invested 40 million euros in the Liège pharmaceutical company Mithra. Coucke is now the second largest shareholder, be…

POPULAR TAGS

European money for Belgian science!

Written by DS on in the category news with the tags .


Can snake venom help to cure diabetes? Can you charge an electric car while driving? Can we make more people play football and hence reduce heart disease? And is pork healthier if we feed the animals with residues of olive oil mixed with soy and grains?

These are just some of the Belgian research projects for which the European Commission has granted money. They announced that they will assign 8.5 billion euros in a new financing round of the Horizon 2020 program. The program runs from 2014 to 2020 and disposes of 77 billion euros during that period.

The biggest part of the budget goes to Leuven. The KU Leuven is on top of the list, followed by its research institute IMEC. Together they receive 117 million euros. Next is Ghent University. Also in Wallonia, a couple organizations appear in the top ten i.e. the University of Louvain-La-Neuve and GlaxoSmithKline (Rixensart).

The situation in Brussels is less clear, because there are also European research institutes located. Here, Cost Association, an alliance of scientists, receives 89 million euros..

The quest for European money has become an important strategy of universities, because it makes them financially less dependent on the government and the business world. Often, researchers only make money if they collaborate with researchers in other EU countries.

Read more about: .

RELATED ARTICLES
Costs for treatment of HIV

The University of Hasselt and the AIDS Reference Centre of Ghent University Hospital calculated that the treatment for people infected with HIV in…


Galapagos thinks big

Galapagos, the Mechelen biotech company, quit its inflammation alliance with Janssen under mutual agreement. Galapagos regained the proprietary ri…


Mithra to become the new Omega Pharma?

Businessman Marc Coucke has invested 40 million euros in the Liège pharmaceutical company Mithra. Coucke is now the second largest shareholder, be…

POPULAR TAGS

Sign up to our Mailing List to receive updates
of our latest News, Events & Magazines

V-Bio Ventures Flanders.bio Biowin Turnstone Itera Life Science UGent GSK XpandInnovation KU Leuven Janssen

ABOUT BIOVOX - Sharing Life Sciences Innovations

BioVox showcases interesting life sciences breakthroughs for and from Belgian innovators. Through our partnership with BioCentury we share relevant worldwide innovations and business updates while our local journalists focus on regional highlights. 

Interested to get involved? Get in touch! We are looking for content, writers and partners! Blogs are available for research institutes, companies and freelance experts.

You want to reach out to the biotechnology and life sciences community, targetting selected audiences? Discover our sponsor and publication opportunities as well as tailored packages!

Contact BioVox via news@biovox.be or by completing the contact form.